There were a couple of new bits of info in the half yearly or else I missed them earlier.
. . . The Phase 2 stage of the HER-Vaxx trial in HER-2 positive gastric cancercommenced in February 2019. . . I guess we'll see something like a first patient dosed announcement soon.
. . . The feasibility of adding an Indian cohort to assist inrecruitment along with the other regions is currently under evaluation.. . it seems they're really keen to run this trial through ASAP.
The embargo on the 1B presentation details is interesting. Why is it needed? Funny thing to make a point of announcing. The LT info is still missing, could that be the missing info that's in the presentation? All a bit secret squirrel really.
Cheers
There were a couple of new bits of info in the half yearly or...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2275218 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 196677 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
